NATO DIANA: Human Resilience & Biotechnology

Finland · 2026 cohort

Develops biomedical and health monitoring research in support of extreme-environment operations.

Germany · 2026 cohort

Develops robotic exoskeletons to support and augment soldiers in physically demanding missions.

Canada · 2026 cohort

Develops a whole-blood conversion unit converting A, B and AB-type blood into universal blood.

United Kingdom · 2026 cohort

Develops rapid blood diagnostics and point-of-care testing for battlefield medical triage.

France · 2026 cohort

Develops ultrasensitive and ultrafast immunoassays for rapid toxin detection.

Canada · 2026 cohort

Develops a drillless bone-fracture fixation solution for austere surgical environments.

Canada · 2026 cohort

Develops on-edge, multi-diagnostic AI for real-time detection of traumatic torso injuries.

Netherlands · 2026 cohort

Develops wearable systems reducing cognitive load and improving situational awareness.

United Kingdom · 2026 cohort

Develops precision phage therapy for treating battlefield infections resistant to antibiotics.

Germany · 2026 cohort

Develops detection technologies for biological and chemical threat agents.

United States · 2026 cohort

Develops a rugged, head-worn telemedicine device for hands-free use in austere environments.

United Kingdom · 2026 cohort

Develops photodynamic therapeutics and research tools for field wound treatment.

Germany · 2026 cohort

Develops anti-infective solutions for treating drug- resistant bacterial infections in the field.

United Kingdom · 2026 cohort

Develops synthetic platelet products for haemorrhage control in combat casualty care.

United States · 2026 cohort

Develops reliable oxygen delivery solutions as alternatives to blood transfusion in trauma care.